Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | GGPS1 | O95749 | 6/20 | 0.36 |
| ▸ | FDPS | P14324 | 9/20 | 0.35 |
| ▸ | SMPD1 | P17405 | 2/20 | 0.34 |
| ▸ | CES2 | O00748 | 1/20 | 0.34 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.34 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3410810 | 1.00 | LMNA (0.37) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| SCHEMBL3408846 | 1.00 | LMNA (0.37) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| SCHEMBL3411605 | 0.98 | SMN1; SMN2 (0.35) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| SCHEMBL3410669 | 0.91 | ALDH1A1 (0.32) | ALDH1A1FDPS | |
| SCHEMBL7796670 | 0.87 | LMNA (0.48) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| SCHEMBL7796853 | 0.87 | LMNA (0.48) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| SCHEMBL1841682 | 0.87 | LMNA (0.48) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| SCHEMBL2109769 | 0.87 | LMNA (0.48) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| SCHEMBL2112471 | 0.87 | LMNA (0.48) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| SCHEMBL868277 | 0.87 | LMNA (0.48) | LMNAALDH1A1HSD17B10MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210104339-A1 | CONDUCTIVE COMPOSITION AND METHOD FOR FABRICATING MICRO LIGHT-EMITTING DIODE DISPLAY | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2021-04-08 | — | — | US | claimed |
| CN-112599508-A | Conductive composition and method for manufacturing micro light-emitting diode display device | 财团法人工业技术研究院 | 2021-04-02 | — | — | CN | claimed |
| EP-2205203-B1 | NOVEL COMPOUNDS PREPARED BY ADDING AN OXETANE DERIVATIVE TO AN ALCOHOL | CECALC (FR) | 2013-01-23 | — | — | EP | claimed |
| US-8258189-B2 | Compounds prepared by adding an oxetane derivative to an alcohol | CECALC (FR) | 2012-09-04 | — | — | US | claimed |
| US-20100216894-A1 | NOVEL COMPOUNDS PREPARED BY ADDING AN OXETANE DERIVATIVE TO AN ALCOHOL | CECALC (FR) | 2010-08-26 | — | — | US | claimed |
| EP-2205203-A1 | NOVEL COMPOUNDS PREPARED BY ADDING AN OXETANE DERIVATIVE TO AN ALCOHOL | Société d'Exploitation de Produits pour les Industries Chimiques SEPPIC (FR) | 2010-07-14 | — | — | EP | claimed |
| WO-2009050405-A1 | NOVEL COMPOUNDS PREPARED BY ADDING AN OXETANE DERIVATIVE TO AN ALCOHOL | SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC (FR) | 2009-04-23 | — | — | WO | claimed |
| US-20210104339-A1 | CONDUCTIVE COMPOSITION AND METHOD FOR FABRICATING MICRO LIGHT-EMITTING DIODE DISPLAY | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2021-04-08 | — | — | US | disclosed |
| CN-112599508-A | Conductive composition and method for manufacturing micro light-emitting diode display device | 财团法人工业技术研究院 | 2021-04-02 | — | — | CN | disclosed |
| EP-2205203-B1 | NOVEL COMPOUNDS PREPARED BY ADDING AN OXETANE DERIVATIVE TO AN ALCOHOL | CECALC (FR) | 2013-01-23 | — | — | EP | disclosed |
| US-8258189-B2 | Compounds prepared by adding an oxetane derivative to an alcohol | CECALC (FR) | 2012-09-04 | — | — | US | disclosed |
| US-20100216894-A1 | NOVEL COMPOUNDS PREPARED BY ADDING AN OXETANE DERIVATIVE TO AN ALCOHOL | CECALC (FR) | 2010-08-26 | — | — | US | disclosed |
| EP-2205203-A1 | NOVEL COMPOUNDS PREPARED BY ADDING AN OXETANE DERIVATIVE TO AN ALCOHOL | Société d'Exploitation de Produits pour les Industries Chimiques SEPPIC (FR) | 2010-07-14 | — | — | EP | disclosed |
| WO-2009050405-A1 | NOVEL COMPOUNDS PREPARED BY ADDING AN OXETANE DERIVATIVE TO AN ALCOHOL | SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC (FR) | 2009-04-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100216894-A1 | NOVEL COMPOUNDS PREPARED BY ADDING AN OXETANE DERIVATIVE TO AN ALCOHOL | ADH1A, ADH5, ADH1C | LMNA 2713/4885ALDH1A1 58/4885HSD17B10 72/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.